NL-OMON34521招募中不适用
PHARMACOKINETICS OF INTRAVENOUS CEFOTAXIME IN CHILDREN - pharmacokineticx of intraveneus cefotaxime in children
Canisius Wilhelmina Ziekenhuis0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •1. Patients who receive intravenous treatment with cefotaxime
- •2. Patients < 18 years
- •3. Written informed consent from the patient and/or their legal guardian
排除标准
- •Patients with a known allergy to cefotaxime or related compounds
研究者
相似试验
进行中（未招募）
1 期
PHARMACOKINETICS OF CEFEPIME AFTER INTRAPERITONEAL ADMINISTRATION VIA CYCLER-THERAPY IN APD PATIENTS WITHOUT PERITONITISCKD 5, Peritoneal DialysisCTIS2023-509930-21-00oe LGA Gesundheit Region Mitte GmbH8
进行中（未招募）
1 期
Pharmacokinetica of CefuroximeEUCTR2016-001511-20-DEInstitute for Pharmacology and Toxicology40
进行中（未招募）
1 期
the study of an antibiotic - cefuroxime - in the post-operative period in infants who have undergone cardiac surgerypost operative paediatric cardiac patientsMedDRA version: 19.1Level: PTClassification code 10053840Term: Bacterial sepsisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2016-002926-35-GBAlder Hey Children's Foundation NHS Trust
已完成
不适用
The effect of two dosing regimens cefotaxime on the presence of potential pathogenic micro-organisms in airways.in potential harmful bacteriapotential pathogenic microorganisms10024970NL-OMON33091Medisch Centrum Haaglanden104
已完成
2 期
The effect of cefotaxime on improvement of pediatric dysenteryDysentery.Gastroenteritis and colitis of unspecified originIRCT2016102211145N18Vice Chancellor of Research and Technology, Kashan University of Medical Sciences100